Talk:Fenugreek

message: The source mentioned (Josephus) does not support the claim that fenugreek was grown as a staple food in Galilee. The quote (see ann. 9) only mentions it as an (unusual) means in warfare. In De Bello there is not more than what is quoted here.--Anfeld (talk) 07:53, 7 May 2022 (UTC)
thread_title:  Staple food in Galilee? 

message: This edit concerning this 2022 review is highlighted as a concern because the review's authors plainly explain the extensive weaknesses of studies included, such as by concluding "the low quality of the included papers, the vast amount of heterogeneity in the data, and research involving patients with various metabolic conditions; extrapolating of our findings to the general population should be with caution." In the review under 3.1. Systematic review and study characteristics, the authors explain the high degree of variability in studies included, all of which were observational in design, i.e., in the category of low-quality evidence, according to WP:MEDASSESS. 
Studies like this are of dubious value in writing for the encyclopedia - I recommend we not include it. Until we have higher quality research to report, the last paragraph of the research section adequately explains the weak state of science and absence of effect by fenugreek on human health. Zefr (talk) 02:04, 8 December 2022 (UTC)
thread_title:  Whether to cite a weak review 

message: Source 4 specifies: "Several coumarin compounds have been identified in fenugreek seeds, as well as a number of alkaloids (eg, trigonelline, gentianine, carpaine), including the alkaloid hydroxyisoleucine, which is considered to stimulate insulin secretion." (The drugs.com source)
Helpful data to include, especially for further researching the potential side effects. Bromallium (talk) 20:49, 2 July 2023 (UTC)
thread_title:  Hypoglycemia Risk - Mechanism? 

message: This revert was justified because the review authors describe in the results and conclusions the study's "significant limitations" which include 1) low quality of the included research, 2) vast heterogeneity of the data analyzed, 3) heterogeneity of the subjects having various disorders of metabolic syndrome, which is a complex of several subdiseases, and 4) extreme range of doses and durations used in the studies included (25 to 60000 mg/day and durations of dosing for 2 to 144 weeks). Not assessed or discussed are dietary and lifestyle factors impossible to control unless the subjects in the underlying studies were in a controlled environment (such as a hospital clinical trial unit).
These variations and limitations in study design and error control emphasize the overall variable, poor quality of dietary supplement and food studies of fenugreek or any dietary element. Reaching a conclusion for the article "that fenugreek could meaningfully " affect biomarkers of metabolic diseases is misleading and not a conclusion that any reputable clinical organization would state - see top of left pyramind, WP:MEDASSESS. 
For the encyclopedia - which should be presenting clear facts supported by scientific consensus (not available for any review on fenugreek) - such limitations warrant the review not be included in the article. Zefr (talk) 17:48, 9 February 2024 (UTC)
thread_title:  Dubious effects on metabolic syndrome